cells produce electrophilic products with the potential to modify and affect the function of proteins. chemoproteomic methods have provided a means to qualitatively inventory proteins targeted by endogenous electrophiles; however, ascertaining the potency and specificity of these reactions to identify the sites in the proteome that are most sensitive to electrophilic modification requires more quantitative methods. here we describe a competitive activity-based profiling method for quantifying the reactivity of electrophilic compounds against >1,000 cysteines in parallel in the human proteome. using this approach, we identified a select set of proteins that constitute 'hot spots' for modification by various lipid-derived electrophiles, including the oxidative stress product 4-hydroxy-2-nonenal (hne). We show that one of these proteins, ZAK kinase, is labeled by hne on a conserved, active site-proximal cysteine and that the resulting enzyme inhibition creates a negative feedback mechanism that can suppress the activation of JnK pathways normally induced by oxidative stress.
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The functional diversity of mammalian proteomes is enriched by the post-translational modification of proteins 1 . Many such modifications are enzyme catalyzed, but others reflect the direct (non-enzymatic) oxidative or electrophilic modification of nucleophilic residues, such as cysteine, by reactive small molecules that are often the products of oxidative stress 2, 3 . Chronic inflammation or hypoxia, for instance, induces the peroxidation of polyunsaturated lipids to generate a broad range of electrophilic products 2 . These lipid-derived electrophiles (LDEs) can modify DNA and proteins to promote cytotoxicity and have been implicated in the pathogenesis of many diseases 4 . A growing body of studies also suggests that, at lower, more physiologically standard concentrations, LDEs serve as endogenous messengers that modulate the response of signaling pathways 5, 6 . HNE, for instance, is a major product generated when free radicals initiate the non-enzymatic fragmentation of lipids in biological membranes 2, 7 . The levels of HNE and HNE-protein adducts are elevated in cells and tissues exposed to oxidative stress, and HNE can regulate redox-responsive signaling pathways by mechanisms that are still poorly understood 2, 8, 9 . 15-Deoxy-∆12,14-prostaglandin J2 (15d-PGJ2) is another LDE produced by a set of enzymes that metabolize arachidonic acid 10 . 15d-PGJ2 exhibits anti-inflammatory and cytoprotective properties and has therefore been designated as a pro-resolving signal 10 . A third example is 2-trans-hexadecenal (2-HD), which is a product of sphingolipid metabolism and has recently been shown to function as a protein-modifying cofactor that promotes mitochondrial pathways for apoptosis 11 .
Understanding the protein targets of LDEs is critical for elucidating their cellular functions and mechanisms of action. Chemoproteomic methods have proven particularly useful for inventorying a large number of proteins that react with LDEs in cells and tissues 2, [12] [13] [14] [15] [16] [17] ; however, quantifying the potency and specificity of these reactions to identify the sites in the proteome that are most sensitive to electrophilic modification has proven challenging. Here we describe a competitive activity-based protein profiling (ABPP) method for quantifying the reactivity of electrophilic compounds against >1,000 cysteines in parallel in the human proteome. Using this approach, we identified select sets of proteins that are preferentially modified by HNE and 15d-PGJ2. We show that the kinase ZAK is labeled by HNE on a conserved, active site-proximal cysteine residue, which inhibits the enzyme and suppresses the activation of JNK pathways by oxidative stress in cancer cells.
results

Quantitative proteomic profiling of lde-cysteine reactions
Among the 20 protein-coding amino acids, cysteine is unique owing to its high nucleophilicity, which renders it sensitive to modification by endogenous and exogenous electrophiles and oxidants 3 . Cysteine reactions with electrophilic metabolites have been characterized for purified proteins 18, 19 and, on a global scale, in cells and tissues using mass spectrometry-based chemoproteomic 2,12-17 and imaging methods 20 . These studies-along with analytical, quantum mechanical and kinetic work 21, 22 have, for the most part, confirmed the preferential reactivity that Michael acceptor electrophiles such as HNE show for cysteine over other nucleophilic amino acids (for example, lysine or histidine) in proteomes. We were interested in building on these past findings to determine whether individual cysteines in the proteome display differences in their reactivity with LDEs and, if so, whether potential hot spots for electrophile modification might constitute key nodes in signaling pathways of redox sensing and response.
We previously described a chemoproteomic method termed isotopic tandem orthogonal proteolysis-ABPP (isoTOP-ABPP) and its use to quantify the intrinsic reactivity of cysteine residues in cell and tissue proteomes 23 . Here we envisioned that isoTOP-ABPP could be advanced to discover and quantify reactions between cysteines and electrophilic small molecules in proteomes. In this 'competitive' version of isoTOP-ABPP (Fig. 1a,b) , a proteome is treated with an electrophile (experimental sample) or dimethyl sulfoxide (DMSO; control sample). Both proteomic samples are then labeled with an alkynylated iodoacetamide (IA) probe (Fig. 1b) and conjugated by copper-catalyzed azide-alkyne cycloaddition (CuAAC, or 'click' 24 ) chemistry to light and heavy azide-biotin tags, respectively, each containing a tobacco etch virus (TEV) cleavage sequence. The light and heavy samples are then mixed and subjected to our described isoTOP-ABPP protocol for peptide enrichment, cleavage and identification, in which IA-modified cysteines are identified and their extent of labeling quantified according to mass spectrometry MS2 and MS1 profiles, respectively 23 . Electrophile-sensitive cysteines are quantified by measuring the MS1 chromatographic peak ratios (R values) for heavy (DMSO-treated) over light (electrophiletreated) samples, with higher R values reflecting greater sensitivity to the electrophile. In this format, competitive isoTOP-ABPP can assay electrophiles against >1,000 cysteines in parallel directly in native proteomes without requiring any chemical modification to the electrophiles themselves.
We applied competitive isoTOP-ABPP to quantitatively profile the proteome reactivity of three LDEs-HNE, 15d-PGJ2 and 2-HD-each of which possesses an α, β−unsaturated carbonyl that can react with nucleophilic cysteines via Michael addition (Fig. 1c) . Competitive isoTOP-ABPP experiments were performed in quadruplicate using the soluble proteome of the human breast cancer cell line MDA-MB-231. Proteomes were treated with 100 µM of HNE, 15d-PGJ2 or 2-HD for 60 min and then with the IA-probe (100 µM, 60 min). A total of ~1,000 cysteine reactivities were quantified across the aggregate data set, with at least 750 cysteine reactivities quantified for each LDE (Fig. 2a) , more than 550 of which were quantified for all the three LDEs ( Supplementary  Fig. 1 and Supplementary Table 1) . Most of the cysteine reactivities (>98%) were unaffected or only marginally affected by LDE treatment (R < 5); however, a select subgroup showed marked reductions in their IA-probe reactivities (R > 5) following exposure to one or more LDEs (Fig. 2a) . HNE and 15d-PGJ2 both targeted several cysteines in the proteome, the majority of which showed preferential reactivity with one of the two LDEs, whereas 2-HD exhibited no detectable high-sensitivity (R > 5) targets (Fig. 2a) . We also analyzed LDEs in a second human cancer cell proteome (Ramos cells), which increased our proteome coverage (>900 cysteines reactivities quantified for all three LDEs) and revealed good overall correlation of reactivity profiles compared to MDA-MB-231 proteomes (Supplementary Fig. 2 ). 
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The quantitative ranking of cysteines based on the magnitude and selectivity of their inhibition illuminated hot spots for LDE reactivity in the proteome (Fig. 2a,b, Supplementary Table 2 and Supplementary Fig. 2 ). Examples included Cys22 of ZAK and Cys848 of MMS19, which were strongly and selectively blocked by HNE and 15d-PGJ2, respectively (Fig. 2c) . Competitive iso-TOP-ABPP also identified several proteins that possess multiple IA-reactive cysteines, only one of which proved sensitive to competitive blockade by an LDE (Fig. 2d ). These data demonstrate that the quantified R values reflect measurements of individual LDE-cysteine reactions rather than general changes in protein abundance potentially caused by LDE exposure. We also found that LDE-sensitive cysteines spanned a broad range of intrinsic reactivity ( Supplementary Fig. 3 ), as determined previously by measuring their extents and rates of IA labeling 23 , a result suggesting that their modification by LDEs depends not only on cysteine nucleophilicity but also on molecular recognition of the LDEs.
determining the potency of hne-cysteine reactions
We next focused on identifying the most sensitive sites for LDE reactivity in the proteome. The MDA-MB-231 cell proteome was treated with varying concentrations of HNE (5, 10, 50, 100 and 500 µM) for 60 min, and then the IA labeling profile of each reaction was quantitatively compared to a DMSO-treated control sample by isoTOP-ABPP. By combining the R values at all five HNE concentrations, we could extrapolate the half-maximal inhibitory concentrations, or IC 50 values, for HNE blockade of IA-probe labeling for ~700 of the ~1,100 total cysteines detected in the study ( Fig. 3a and Supplementary Table 3 ). This analysis revealed that the vast majority of cysteines were (Fig. 3a,b) . We next confirmed that these hypersensitive cysteines were also inhibited by HNE in situ by treating MDA-MB-231 cells with 50 or 100 µM HNE and then preparing proteomes for analysis by competitive isoTOP-ABPP (Fig. 3c,d and Supplementary Table 4) . Another set of cysteines showed reductions in IA-probe labeling in situ but not in vitro (Fig. 3d) . This finding suggests that certain proteins may preferentially react with HNE in living cells, although we cannot exclude, at this point, that the reductions in IA-probe labeling observed for these proteins reflect a decrease in their overall abundance in HNE-treated cells.
Functional analysis of hne modification of ZAK kinase
ZAK kinase (also known as MLK7 or MLTK) functions as a mitogen-activated kinase kinase kinase (MAP3K) that can activate all three major MAPK (ERK, JNK and p38) pathways in mammalian cells [25] [26] [27] , with some preference for JNK 26 , and is involved in responding to stressors such as UV radiation 28 and chemotherapeutic agents 27 . Sequence and structure comparisons allowed us to map the HNE-sensitive cysteine in ZAK (C22) to a location proximal to the glycine-rich ATP-binding loop ('P-loop') ( Fig. 4a) . Interestingly, among all 20 human MAP3Ks, ZAK is the only member that possesses a cysteine at this position (Fig. 4a) , and this cysteine is highly conserved across ZAK orthologs in vertebrates ( Supplementary Fig. 4 ). This information, combined with the high sensitivity displayed by Cys22 for HNE (Fig. 3a) motivated us to further characterize this interaction and its impact on ZAK activity. We first expressed Flag-tagged versions of wild type (WT) and a C22A mutant of ZAK by stable transfection in HEK-293T cells and found that WT ZAK showed much stronger IA-rhodamineprobe labeling as measured by gel-based ABPP. The IA-rhodamine labeling of WT ZAK was blocked by pretreatment with HNE over a concentration range that closely matched the HNE-sensitivity profile observed for Cys22 in competitive isoTOP-ABPP experiments ( Fig. 4b; compare to Fig. 3a) . We next used an alkynefunctionalized HNE probe (HNEyne) 12 to verify that WT ZAK was directly labeled, and that the C22A ZAK mutant was not, in vitro and in living cells (Fig. 4c) . HNE also inhibited WT but not C22A ZAK activity in a concentration-dependent manner, as measured with an in vitro myelin basic protein (MBP) substrate assay 29 ( Fig. 4d) . We note that C22A ZAK exhibited reduced basal activity compared to WT ZAK, but the residual activity of C22A ZAK, which was still much greater than a catalytically dead K45M ZAK mutant, was insensitive to HNE ( Fig. 4d and Supplementary  Fig. 5 ). Considering that Cys22 is predicted to reside adjacent to the ATP-binding loop of ZAK, we postulated that the HNE-induced loss of kinase activity might be due to blockade of ATP binding. We tested this hypothesis by performing a competitive stable-isotope labeling by amino acids in cell culture (SILAC)-ABPP 30 experiment using an acyl phosphate-ATP probe 31 , which revealed that probe labeling of ZAK, but not of other proteins, was substantially reduced in cell proteomes treated with HNE (Fig. 4e) .
hne modification of ZAK suppresses JnK activation in cells
We next evaluated the activation state of MAPK signaling pathways in HEK-293T cells stably expressing WT ZAK, C22A ZAK or K45M ZAK. WT ZAK-expressing cells, but not C22A or K45M ZAK-expressing cells, showed increased JNK and, to a lesser extent, p38 and ERK pathway activation compared to mocktransfected cells, as measured by anti-phosphoprotein blotting (Fig. 5a,b and Supplementary Fig. 6 ). We next treated cells with H 2 O 2 (1 mM, 30 min) to induce oxidative stress, a process that is known to activate the JNK pathway 32 LQFFENCGGGSFGSVYR  MAP3K1 WLKGQQIGLGAFSSCYQ  MAP3K2 -RLGKLLGQGAFGRVYL  MAP3K3 WRRGKLLGQGAFGRVYL  MAP3K4 WQRGNKIGEGQYGKVYT  MAP3K5 NGDRVVLGKGTYGIVYA  MAP3K6 TGERLVLGKGTYGVVYA  MAP3K7 IEVEEVVGRGAFGVVCK  MAP3K8 NIGSDFIPRGAFGKVYL  MAP3K9 LTLEEIIGIGGFGKVYR  MAP3K10 LQLEEIIGVGGFGKVYR  MAP3K11 LRLEEVIGIGGFGKVYR  MAP3K12 ILDLQWVGSGAQGAVFL  MAP3K13 ISELQWLGSGAQGAVFL  MAP3K14 ATHQLRLGRGSFGEVHR  MAP3K15 NGERVVLGKGTYGIVYA  MAP3K16 FTDLREIGHGSFGAVYF  MAP3K17 FSDLREIGHGSFGAVYF  MAP3K18 FIGLHEIGHGSFGAVYF  MLK4 npg the greater level of activation (Fig. 5b,c) . Strikingly, however, pretreatment with HNE (100 µM, 30 min) produced opposing effects in WT-and C22A-ZAK cells, blocking H 2 O 2 -dependent JNK activation in the former cell model and hyperactivating JNK activity in the latter. We interpret these findings to indicate the existence of both ZAK-dependent and ZAK-independent pathways for HNE modulation of JNK activation (Fig. 5d) . By modifying Cys22 on ZAK, HNE blocks the contribution that this kinase makes to activation of the JNK pathway. HNE is also known to itself promote oxidative stress 33 that likely adds to the effects of H 2 O 2 and, in the context of an HNE-resistant C22A ZAK mutant, would serve to further augment activation of the JNK pathway. In this model, the HNE-ZAK interaction acts as a negative feedback loop that tempers activation of the JNK pathway under high and/or persistent levels of oxidative stress (Fig. 5d) . We further tested this idea by evaluating the effects of HNE alone on JNK pathway activity in ZAK-expressing cells. A dramatic concentration-dependent activation of JNK was observed in C22A-ZAK cells but not in WT-ZAK cells, which showed higher basal JNK activation that was mostly unaffected by HNE (Fig. 5e,f) . Although we were initially surprised that HNE treatment did not appear to block the basal JNK activation caused by WT ZAK, we should note that HNE also activated JNK in mock-transfected cells to a level that matched the basal JNK activity observed in WT ZAK-transfected cells. Thus, the residual JNK activation observed in WT ZAK-transfected cells may reflect ZAKindependent pathways of JNK activation by HNE (Fig. 5e,f) . That JNK activation was much higher in C22A-ZAK cells than in the other cell models indicates this HNE-insensitive form of ZAK, which still retains some catalytic activity (Fig. 4d) , combines with ZAK-independent, HNE-stimulated pathways to further enhance JNK activation.
discussion
Long viewed as biomarkers of oxidative damage, LDEs have more recently gained attention as second messengers that can regulate diverse cellular processes 5, 34 . Considering that the signaling and pathophysiological functions of LDEs may differ across the endogenous concentration ranges found for these compounds, it is imperative to understand the potencies of LDE-protein interactions in biological systems. With this goal in mind, we created a competitive isoTOP-ABPP platform to quantitatively map LDE-reactivity across >1,000 cysteines in parallel, resulting in the discovery of discrete sites of hypersensitivity, or hot spots, for LDE modification in the human proteome. Among the most LDE-sensitive cysteines, Cys22 of ZAK captured our interest because of the proposed role of this kinase in activating JNK, ERK and p38 MAPK pathways in both cancer 25 and inflammation 27 . To date, only a handful of studies have investigated ZAK function, and its modes of regulation remain poorly understood. That HNE inhibits human ZAK by modifying an active site-proximal cysteine conserved among ZAK orthologs, but not other MAP3K enzymes, suggests that ZAK acts as a special node in MAPK signaling pathways that confers sensitivity to lipid oxidation products. In this way, HNE modification of ZAK may limit the extent of JNK activation caused by oxidative stress, which could help certain cell types, such as tumor and immune cells, survive in the presence of high levels of reactive oxygen species. Further studies of ZAK function would benefit from the development of selective inhibitors for this enzyme. It is noteworthy, in this regard, that covalent inhibitors targeting active-site cysteine residues have recently been introduced for many kinases 35 , leading us to speculate that the Cys22-HNE interaction discovered herein may offer a medicinal chemistry starting point for the development of ZAK inhibitors. Beyond ZAK, we also identified several other kinases in our competitive isoTOP-ABPP experiments that possess cysteines inhibited by HNE, albeit with lower potencies (Supplementary Table 5 ). Prominent among these was cysteine (Cys311) in AKT1/2/3, which is an active site-proximal residue implicated in substrate binding 36 and was inhibited by HNE with an IC 50 value of ~60 µM (Supplementary Table 3) . These proteomic findings confirm recent work showing that recombinant AKT2 is modified by HNE on Cys311 (ref. 18 ). 
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We believe that competitive isoTOP-ABPP offers several advantages over more conventional proteomic approaches for the discovery and characterization of protein-small molecule reactions in biological systems. First, quantitative inhibition values are measured in relative terms that are independent of absolute protein abundance. The method is therefore able to sift through signals that span a broad range of intensities to identify reactive sites that are more likely to bear functional consequence. Here the site specificity afforded by isoTOP-ABPP is important because it permits the discovery of potent electrophile-cysteine reactions that may occur on proteins that display other unaffected and/or nonfunctional cysteines (Fig. 2d) . Endogenous electrophiles also vary considerably in their structures and the stability of the protein adducts that they form. These features can complicate the direct detection of electrophile-protein interactions in proteomics studies. By competitively assessing electrophile-protein interactions using a structurally simple IA probe that forms stable adducts with cysteines, isoTOP-ABPP affords a robust and uniform way to detect and quantify cysteine-electrophile adducts in proteomes by mass spectrometry. The method should also prove applicable to profiling electrophileprotein reactions in primary cells and/or tissues 23 , as isotopic tags are conveniently appended to these adducts by click chemistry.
There are, however, some potential shortcomings of competitive isoTOP-ABPP. Because this method indirectly identifies sites of electrophile action by competitive displacement, it remains possible that, in certain instances, blockade of IA-probe labeling could be due to electrophile modification of a neighboring residue rather than the IA-labeled cysteine itself. We addressed this potential concern for ZAK by follow-up studies using a clickable HNE probe 12 , which labeled WT ZAK but not a C22A ZAK mutant. We envision that a similar strategy could be used to confirm additional LDE-cysteine interactions discovered in competitive isoTOP-ABPP experiments. Competitive isoTOP-ABPP may also fail to detect certain electrophile-cysteine reactions that occur on very low-abundance proteins or on nonproteotypic peptides incompatible with mass spectrometric detection. Alternative protease digestion protocols should prove capable of identifying at least a subset of these electrophile-cysteine reactions. We should further note that, although the potency of LDE-cysteine reactions is likely important for proteins that are inhibited by LDEs in cells, this parameter may be less relevant for LDE-cysteine reactions that stimulate protein function 2, 9 . Indeed, only a modest level of LDE modification may be needed to activate some signaling pathways such as, for instance, the HNE-mediated induction of the heat-shock response by modifying heat-shock proteins to release bound HSF1 (refs. 2,9) . We identified several lowerpotency, IA-reactive cysteines in Hsp90 (Supplementary Fig. 7) , and it is possible that one or more of these HNE-cysteine reactions contributes to disrupting Hsp90-HSF1 interactions. Finally, natural electrophiles are also known to target amino acids beyond cysteine 14, 37 , and these reactions could be quantitatively profiled by adapting competitive isoTOP-ABPP to map other nucleophilic amino acids in proteomes. For this, the continued exploration of simple reactive groups that preferentially and stably modify specific amino acid side chains in proteins is warranted 38, 39 . methods Methods and any associated references are available in the online version of the paper. comPeting FinAnciAl interestsonline methods Preparation of human cancer cell line proteomes. MDA-MB-231 cells (from ATCC) were grown in L15 medium supplemented with 10% FBS at 37 °C in a CO 2 -free incubator. For in vitro labeling experiments, cells were grown to 100% confluency, washed three times with PBS and scraped in cold PBS. Ramos cells (from ATCC) were grown in RPMI medium supplemented with 10% FBS at 37 °C in a 5% CO 2 incubator, and cells were harvested at a density of 10 6 cells/mL. Cell lines were confirmed to be negative for mycoplasma contamination at the time of acquisition and were frozen at early passages before expansion and use. MDA-MB-231 and Ramos cell pellets were isolated by centrifugation at 1,400g for 3 min, and the cell pellets were stored at −80 °C until further use. The harvested cell pellets were lysed by sonication in PBS buffer and fractionated by centrifugation (100,000g, 45 min) to yield soluble and membrane proteomes. The proteomes were prepared fresh from the frozen cell pallets before each experiment.
In vitro LDE treatment. HNE was purchased from EMD Biosciences, 15d-PGJ2 was purchased from Cayman Chemicals and 2-HD was purchased from Santa Cruz Biotechnology. Proteome samples were diluted to a 4 mg protein/mL solution in PBS. For each profiling experiment, one aliquot of the proteome sample (0.5 mL) was treated with 100 µM of LDE using 5 µL of a 10 mM stock, and the other aliquot was treated with 5 µL of either ethanol (for HNE and 15d-PGJ2) or DMSO (for 2-HD) as control. Samples were prepared in at least four replicates for each proteome-LDE combination. For the concentration-dependent profiling experiments using HNE, aliquots of the proteomes (0.5 mL each) were treated with 5, 10, 50, 100 and 500 µM of HNE using 5 µL of 0.5, 1.0, 5, 10 and 50 mM of stock solution, respectively. After 60 min of treatment at room temperature, both the LDE-treated and control aliquots were passed through a NAP-5 Sephadex column (GE Healthcare) to remove any unreacted LDE. The volume of each aliquot was increased to 1 mL with the concentration at 2 mg/mL after this step.
In situ HNE treatment. After MDA-MB-231 cells were grown to 100% confluency, the medium was removed and replaced with fresh serum-free medium containing 50 or 100 µM HNE (10 or 20 µL of 50 mM stock in ethanol in 10 mL of medium). A control flask of cells was treated with 10 mL of serum-free medium containing 10 or 20 µL of ethanol in parallel. The cells were incubated at 37 °C for 1 h and harvested as detailed above to prepare HNE-treated and control proteomes, respectively. Samples were prepared in duplicate.
Protein labeling and click chemistry. Each of the control and LDEtreated proteome samples (~2 mg protein/mL in 1-mL volume) was treated with 100 µM of IA probe using 10 µL of a 10 mM stock in DMSO. The labeling reactions were incubated at room temperature for 1 h. Click chemistry was performed by the addition of 100 µM of either the heavy-TEV-tag (for the control sample) or light-TEV-tag (for the LDE-treated sample) (20 µL of a 5 mM stock), 1 mM TCEP (fresh 50× stock in water), 100 µM ligand (17× stock in DMSO:t-butanol 1:4) and 1 mM CuSO 4 (50× stock in water). Samples were allowed to react at room temperature for 1 h. After the click chemistry step, the light-and heavylabeled samples were centrifuged (5,900g, 4 min, 4 °C) to pellet the precipitated proteins. The pellets were mixed together and washed twice in cold MeOH, after which the pellet was solubilized in PBS containing 1.2% SDS via sonication and heating (5 min, 80 °C). Samples were subjected to streptavidin enrichment of probe-labeled proteins, sequential on-bead trypsin and TEV digestion, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis according to the published isoTOP-ABPP protocol 23 .
MS data analysis.
For each LC-MS/MS run, IA probe-labeled peptides were identified by Sequest 40 and DTASelect 41 , and the quantification of heavy/light ratios (isoTOP-ABPP ratios, R) was performed by an in-house software (CIMAGE) as previously described 23 (available upon request). The software was advanced to be able to detect and quantify cases where near-complete LDE blockade of IA-probe labeling was achieved (for example, very small or no light peak) and assign an empirical ratio cutoff of 15 to each of such cases. After ratios for unique peptides were calculated for each run, overlapping peptides with the same labeled cysteine (for example, same local sequence around the labeled cysteines but different charge states, MudPIT segment numbers, or tryptic termini) were grouped together (as a 'peptide entry'), and the median ratio from each group was recorded as the R ratio of this peptide entry in this run.
For the in vitro profiling with three different LDEs, each experiment (one proteome-LDE combination) contained at least four replicate runs. The R ratios of each peptide entry from multiple replicate runs were averaged, and the mean value was reported as its final R ratio in this experiment. Cases were excluded from further analysis when large variability in R ratios across multiple replicate runs were observed (s.d. >2/3 of the mean) or when R ratios were not quantified in two or more replicate runs for any of the six proteome-LDE experiments.
For the in vitro profiling with HNE competition at different concentrations, all runs were searched using Sequest and filtered with DTASelect as described above. Because the mass spectrometer was configured for data-dependent fragmentation, peptides are not always identified in every run. In the case of probe-modified peptides that were sequenced in one but not the other runs, a featured algorithm of CIMAGE was used to identify the corresponding peak pairs in the runs without the Sequest identification and obtain quantification as previously described.
For the in situ profiling with HNE at 50 and 100 µM, two replicate samples were prepared for each condition (four runs in total). Peptide entries without quantified ratios from at least two runs (either two different concentrations or two replicates at the same HNE concentration) were removed from further analysis.
In all cases, the false positive rate after quantification was found to be less than 1%. All of these values can be found in Supplementary Tables 1, 3 and 4 .
All RAW data and DTASelect files have been deposited in PeptideAtlas under accession number PASS00353.
Retroviral overexpression of Flag-tagged ZAK proteins in HEK-293T cells. Full-length cDNA encoding human ZAK-β (BC001401) in pOTB7 was purchased from Open BioSystems and subcloned into pFLAG-CMV-6c (SigmaAldrich). ZAK-C22A and ZAK-K45M mutants were generated by QuikChange site-directed mutagenesis using the primer npg
